Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein

Journal of Biological Chemistry

Volumn 282, Issue 52, 2007, Pages 37492-37500

  Darnell, Grant A ^a   Schroder, Wayne A ^a   Antalis, Toni M ^b   Lambley, Eleanore ^a   Major, Lee ^a   Gardner, Joy ^a   Birrell, Geoff ^a   Cid Arregui, Angel ^c   Suhrbier, Andreas ^a,d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CELL CULTURE; DEGRADATION; ENZYME ACTIVITY; TUMORS;

HUMAN PAPILLOMAVIRUS; RETINOBLASTOMA PROTEIN;

PROTEINS;

CALPAIN; CALPAIN 1; CALPASTATIN; CISPLATIN; PROTEIN E6; PROTEIN E7; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TRANSCRIPTION REPRESSION; UTERINE CERVIX CANCER; WART VIRUS;

ANIMALS; BETA-GALACTOSIDASE; BINDING SITES; CALPAIN; CELL AGING; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MODELS, BIOLOGICAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN STRUCTURE, TERTIARY; RETINOBLASTOMA PROTEIN;

HUMAN PAPILLOMAVIRUS;

EID: 38049187003     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M706860200     Document Type: Article

References (43)

1. Lowy, D. R., and Schiller, J. T. (2006) J. Clin. Investig. 116, 1167-1173
2. Garnett, G. P., Kim, J. J., French, K., and Goldie, S. J. (2006) Vaccine 24, Suppl. 3, 178-186
3. Hebner, C. M., and Laimins, L. A. (2006) Rev. Med. Virol. 16, 83-97
4. Longworth, M. S., and Laimins, L. A. (2004) Microbiol. Mol. Biol. Rev. 68, 362-372
5. Munger, K., and Howley, P. M. (2002) Virus Res. 89, 213-228
6. Frolov, M. V., and Dyson, N. J. (2004) J. Cell Sci. 117, 2173-2181
7. Helt, A. M., and Galloway, D. A. (2003) Carcinogenesis 24, 159-169
8. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. (1989) Science 243, 934-937
9. Liu, X., Clements, A., Zhao, K., and Marmorstein, R. (2006) J. Biol. Chem. 281, 578-586
10. Scheffner, M., and Whitaker, N. J. (2003) Semin. Cancer Biol. 13, 59-67
11. Wang, J., Sampath, A., Raychaudhuri, P., and Bagchi, S. (2001) Oncogene 20, 4740-4749
12. Boyer, S. N., Wazer, D. E., and Band, V. (1996) Cancer Res. 56, 4620-4624
13. Darnell, G. A., Antalis, T. M., Johnstone, R. W., Stringer, B. W., Ogbourne, S. M., Harrich, D., and Suhrbier, A. (2003) Mol. Cell. Biol. 23, 6520-6532
14. Darnell, G. A., Antalis, T. M., Rose, B. R., and Suhrbier, A. (2005) J. Virol. 79, 4246-4256
15. Tremper-Wells, B., and Vallano, M. L. (2005) J. Biol. Chem. 280, 2165-2175
16. Carragher, N. O. (2006) Curr. Pharm. Des. 12, 615-638
17. Guan, N., Korukonda, R., Hurh, E., Schmittgen, T. D., Donkor, I. O., and Dalton, J. T. (2006) Int. J. Oncol. 29, 655-663
18. Postovit, L. M., Dutt, P., Dourdin, N., Park, M., Greer, P. A., Graham, C. H., and Elce, J. S. (2002) Biochem. Biophys. Res. Commun. 297, 294-301
19. Cid-Arregui, A., Juarez, V., and zur Hausen, H. (2003) J. Virol. 77, 4928-4937
20. Downing, S., Bumak, C., Nixdorf, S., Ow, K., Russell, P., and Jackson, P. (2003) Mol. Carcinog. 38, 130-140
21. Gonzalez, S. L., Stremlau, M., He, X., Basile, J. R., and Munger, K. (2001) J. Virol. 75, 7583-7591
22. Antalis, T. M., La Linn, M., Donnan, K., Mateo, L., Gardner, J., Dickinson, J. L., Buttigieg, K., and Suhrbier, A. (1998) J. Exp. Med. 187, 1799-1811
23. Arthur, J. S., Elce, J. S., Hegadorn, C., Williams, K., and Greer, P. A. (2000) Mol. Cell. Biol. 20, 4474-4481
24. Mailhes, J. B., Hilliard, C., Lowery, M., and London, S. N. (2002) Cell Chromosome 1, 2-8
25. Tompa, P., Buzder-Lantos, P., Tantos, A., Farkas, A., Szilagyi, A., Banoczi, Z., Hudecz, F., and Friedrich, P. (2004) J. Biol. Chem. 279, 20775-20785
26. Rubin, S. M., Gall, A. L., Zheng, N., and Pavletich, N. P. (2005) Cell 123, 1093-1106
27. Rechsteiner, M., and Rogers, S. W. (1996) Trends Biochem. Sci 21, 267-271
28. Kubbutat, M. H., and Vousden, K. H. (1997) Mol. Cell. Biol. 17, 460-468
29. Psyrri, A., DeFilippis, R. A., Edwards, A. P., Yates, K. E., Manuelidis, L., and DiMaio, D. (2004) Cancer Res. 64, 3079-3086
30. Hall, A. H., and Alexander, K. A. (2003) J. Virol. 77, 6066-6069
31. Volbracht, C., Chua, B. T., Ng, C. P., Bahr, B. A., Hong, W., and Li, P. (2005) J. Neurochem. 93, 1280-1292
32. Rojas-Espaillat, L. A., and Rose, P. G. (2005) Curr. Opin. Oncol. 17, 485-492
33. Wesierska-Gadek, J., Schloffer, D., Kotala, V., and Horky, M. (2002) Int. J. Cancer 101, 128-136
34. Siddik, Z. H. (2003) Oncogene 22, 7265-7279
35. Jang, J. S., and Choi, Y. H. (1999) Int. J. Mol. Med. 4, 487-492
36. Fernandez-Montalvan, A., Assfalg-Machleidt, I., Pfeiler, D., Fritz, H., Jochum, M., and Machleidt, W. (2006) Biol. Chem. 387, 617-627
37. Goll, D. E., Thompson, V. F., Li, H., Wei, W., and Cong, J. (2003) Physiol. Rev. 83, 731-801
38. Banerjee, N. S., Genovese, N. J., Noya, F., Chien, W. M., Broker, T. R., and Chow, L. T. (2006) J. Virol. 80, 6517-6524
39. Chen, P. L., Riley, D. J., Chen-Kiang, S., and Lee, W. H. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 465-469
40. Niu, X. Y., Peng, Z. L., Duan, W. Q., Wang, H., and Wang, P. (2006) Int. J. Gynecol. Cancer 16, 743-751
41. Yamato, K., Fen, J., Kobuchi, H., Nasu, Y., Yamada, T., Nishihara, T., Ikeda, Y., Kizaki, M., and Yoshinouchi, M. (2006) Cancer Gene Ther. 13, 234-241
42. Dupont, N. C., and Monk, B. J. (2006) Clin. Adv. Hematol. Oncol. 4, 279-286
43. Putral, L. N., Bywater, M. J., Gu, W., Saunders, N. A., Gabrielli, B. G., Leggatt, G. R., and McMillan, N. A. (2005) Mol. Pharmacol. 68, 1311-1319